PDL BioPharma Inc (NASDAQ:PDLI)

2.48
Delayed Data
As of Feb 23
 -0.02 / -0.80%
Today’s Change
1.96
Today|||52-Week Range
3.55
-9.49%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues66.5M45.4M143.8M62.7M
 
 
 
 
 
Cost of Goods Sold4.1M2.6M4.5M5.6M
 
 
 
 
 
Depreciation And Amortization6.0M6.0M6.1M6.3M
 
 
 
 
 
 
Operating ExpensesGross Income56.4M36.9M133.2M50.9M
 
 
 
 
 
General Expenses15.0M16.9M19.2M17.6M
 
 
 
 
 
Research And Development1.9M1.8M4.3M605.0K
 
 
 
 
 
Total Operating Expenses25.1M25.5M29.8M29.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income41.4M19.9M114.0M33.3M
 
 
 
 
 
Extraordinary Credit5.8M0.00----
 
 
Extraordinary Charge-57.2M-1.4M-1.2M-700.0K
 
 
 
 
 
Interest Expense On Debt4.7M5.0M5.0M5.1M
 
 
 
 
 
Other Expenses184.0K212.0K6.5M-2.0M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.6M13.7M114.3M25.5M
 
 
 
 
 
Income Taxes-4.3M-6.6M-53.9M-4.8M
 
 
 
 
 
Minority Interest-56.0K-47.0K0.000.00
 
 
 
Net Income-10.3M7.2M60.4M20.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS164.0M163.7M155.7M151.1M
 
 
 
 
 
Shares To Calculate EPS Diluted164.5M164.0M156.4M152.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06$0.04$0.39$0.14
 
 
 
 
 
EPS Diluted-$0.06$0.04$0.39$0.14